Author's response to reviews Title: Seropositivity among HPV-16/18 DNA positive young women Authors:

Determinants of seropositivity among HPV-16/18 DNA positive young women

BACKGROUND Not all women infected with HPV-16/18 have detectable levels of HPV-16/18 antibodies, those who seroconvert develop low antibody levels, and seroconversion occurs typically several months post-infection. We evaluated determinants of seropositivity among 646 women infected with HPV-16 and/or HPV-18. METHODS Data are from the enrollment visit of the NCI-sponsored Costa Rica HPV Vacci...

Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.

In the absence of genital samples, human papillomavirus (HPV) serology may be useful to assess HPV infection in young men and women. HPV seroprevalence and determinants of seropositivity were assessed in 817 female and 518 male university students in Busan, South Korea, of whom 74% and 44%, respectively, reported never having had penetrative sexual intercourse. Type-specific HPV DNA status, ass...

Author's response to reviews Title: Is HPV-16 seropositivity a correlate of immunity? Insights from compartmental models Authors:

Author's response to reviews Title: Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip HPV assays Authors:

High-risk types of human papillomavirus (HPV) are the causative agents of cervical cancer. Cervical screening could be improved by testing for the DNA of high-risk types of HPV as a primary screening tool. Authors: Cervical cancer is caused by high-risk types of human papillomavirus (HPV). DNA testing of such high-risk types of HPV could improve cervical screening. Background: High-risk types o...

Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.

The association between seropositivity to virus-like particles (VLP) of human papillomavirus (HPV) types 16, 18, 31, 35, or 45 and subsequent cervical HPV infection was examined in 829 women with HIV and 413 risk-matched HIV-negative women. We found no statistically significant differences between HPV-seropositive and HPV-seronegative women in the risk of a new infection with the homologous HPV...